...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: I Don’t Like Mondays

« ...after three trial failures to date by RVX. »

I think it’s too soon to regard BETonMACE as a failure. The pre-specified subgroup analyses may be important. They are much more reliable than post hoc subgroup analyses. Let’s wait for the AHA. 

Share
New Message
Please login to post a reply